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Background and aims: Previous analyses have highlighted signiﬁcant associations between gambling disorder (GD)/
subsyndromal GD and increased rates of anxiety symptoms and anxiety disorders relative to the general population.
However, less is known about how anxiety symptoms inﬂuence the clinical presentation of gambling problems. The
objective of this study was to evaluate the association between anxiety symptoms, gambling activity, and
neurocognition across the spectrum of gambling behavior. Methods: The sample consisted of 143 non-treatment-
seeking young adults (aged 18–29 years), in which 63 individuals (44.1%) were classiﬁed as recreational gamblers,
47 (32.9%) as having subsyndromal GD, and 33 (23.1%) met criteria for GD. Results: The main ﬁndings were:
(a) there was a positive correlation between anxiety severity and gambling severity measured by the number of DSM-
5 GD criteria met; (b) there was a positive correlation between anxiety severity and attentional impulsiveness;
(c) subjects with suicidality presented higher levels of anxiety; and (d) the severity of anxiety symptoms was
negatively correlated with the quality of life. Discussion and conclusions: This study suggests that anxiety may be
associated with relevant clinical variables in the broad spectrum of gambling activity. Therefore, proper management
of anxiety symptoms might improve the clinical presentation of gamblers in different areas.
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INTRODUCTION
Gambling disorder (GD) is associated with high rates of
depression, substance-use disorders, and suicidality; as
well as occupational and legal problems (Bland, Newman,
Orn, & Stebelsky, 1993; Cunningham-Williams, Cottler,
Compton, & Spitznagel, 1998; Muelleman, DenOtter,
Wadman, Tran, & Anderson, 2002; Petry & Kiluk, 2002;
Petry, Stinson, & Grant, 2005; Toce-Gerstein, Gerstein, &
Volberg, 2003). The annual cost of GD is approximately
5 billion US dollars within the United States alone (National
Gambling Impact Study Commission & James, 1999).
Subsyndromal gambling is also a notable concern, and is
deﬁned as a signiﬁcant gambling activity that does not meet
full DSM-5 criteria for GD (Grant, Derbyshire, Leppink, &
Chamberlain, 2014). Subsyndromal gamblers also show
high rates of depression, anxiety disorders, substance-use
disorders, ﬁnancial, legal, family, and professional problems
(Cunningham-Williams et al., 1998; Desai, 2004; Gerstein
et al., 1999; Grall-Bronnec et al., 2012; Potenza, Maciejewski,
& Mazure, 2006; Shaffer & Korn, 2002; Welte, Barnes,
Wieczorek, Tidwell, & Parker, 2001). Therefore, it is likely
that gambling symptoms present on a continuum, and that
symptoms should be assessed across the spectrum of gam-
bling behavior (Cunningham-Williams et al., 1998; Eisen
et al., 2001; Gerstein et al., 1999; Grant et al., 2014; Shaffer,
Hall, & Vander Bilt, 1999; Shaffer & Korn, 2002; Slutske
et al., 2000; Toce-Gerstein et al., 2003; Welte et al., 2001).
The previous analyses have highlighted signiﬁcant asso-
ciations between GD/subsyndromal GD and increased rates
of anxiety symptoms and anxiety disorders relative to the
general population (Black & Moyer, 1998; Bland et al.,
1993; Cunningham-Williams et al., 1998; Desai & Potenza,
2008; Petry et al., 2005). One large epidemiological study
found a lifetime prevalence of anxiety disorders of 41.3%
among disordered gamblers (Petry et al., 2005). A system-
atic review of epidemiological studies corroborated these
ﬁndings, with 37% of gamblers reporting a history of a
comorbid anxiety disorder (Lorains, Cowlishaw, & Thomas,
2011). In another analysis, Desai and Potenza (2008) also
found a high prevalence of panic disorder, generalized
anxiety, and social phobia in subsyndromal GD.
Although anxiety symptoms are common in gamblers,
less is known about how anxiety symptoms inﬂuence the
clinical presentation of gambling problems. Various lines of
research suggest that anxiety could be a powerful contribu-
tor to gambling behavior. First, the research in other addic-
tions (alcohol-use disorder and substance-use disorder)
suggests that the behavior may be a way to cope with
anxiety (Sher, Trull, Bartholow, & Vieth, 1999). The relief
of the anxiety, however, tends to be short-lived, and the
symptoms may often reappear more intensely. As a result, a
harmful cycle is created, and the anxious individual may
therefore present with a more frequent and severe form of
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the addictive behavior. Second, attentional bias toward
threatening elements is a well-characterized phenomenon
in anxious individuals and, as a result of this, other non-
threatening elements tend to be less perceived (Bar-Haim,
Lamy, Pergamin, Bakermans-Kranenburg, & Van Ijzen-
doorn, 2007; Bishop, Duncan, Brett, & Lawrence, 2004;
Koster, Crombez, Van Damme, Verschuere, & De Houwer,
2004; Koster, Crombez, Verschuere, Van Damme, & Wier-
sema, 2006; MacLeod, Mathews, & Tata, 1986; Mogg &
Bradley, 1998; Schoﬁeld, Johnson, Inhoff, & Coles, 2012).
Therefore, an anxious individual who gambles may have a
reduced focus on the gambling behavior (i.e., how to bet and
how much to bet). This attentional deﬁcit may be another
factor leading to a worse severity of GD. Finally, anxiety
symptoms decrease some dimensions of quality of life
(Spitzer et al., 1995). In this context, the increased emotional
suffering and the lower level of life satisfaction could also
increase the risk of suicide.
In light of this background, the objective of this study
was to evaluate the association between anxiety symptoms,
gambling activity, and neurocognition across the spectrum
of gambling behavior (recreational gamblers, subsyndromal
GD, and GD) in a non-treatment-seeking sample. We
assessed the current severity of anxiety symptoms and asso-
ciations between anxiety symptom severity, gambling symp-
toms, impulsiveness, and neurocognition. We predicted that
anxiety symptoms would be associated with: (a) worse over-
all severity of GD, measured by increased gambling activity
and more losses due to gambling and (b) higher impulsivity
measured with clinical and neurocognitive tasks. In addition,
we expected that anxiety would be correlated with: (c) worse
clinical and neurocognitive attentional performance;
(d) lower quality of life; and (e) higher levels of suicidality.
If our hypotheses are correct, anxiety symptoms would be
associated with variables correlated with poor prognosis and
poor overall functioning. Therefore, proper management of
anxiety should receive greater attention in clinical practice
since it could improve the clinical presentation of gamblers in
multiple domains. If our hypotheses are not supported,
constant assessment and treatment of anxiety would be a
secondary approach in the management of GD.
METHODS
Sample
The sample consisted of 143 non-treatment-seeking young
adults (aged 18–29 years) [n= 75 (52.1%) male; mean age
24.8 (±2.9) years] with varying levels of gambling severity.
Participants were recruited through media advertising
(“have you ever gambled?”), and had gambled at least ﬁve
times during the past year. Also, 63 individuals (44.1%)
were classiﬁed as recreational gamblers (see later for deﬁni-
tions), 47 (32.9%) as having subsyndromal GD, and 33
(23.1%) met criteria for GD.
Procedures
All assessments were completed as a part of an ongoing
study of gambling behavior in young adults. Participants
were compensated with a US$50 gift card to a local
department store. Subjects were recruited in Chicago/IL
and Minneapolis/MN metropolitan areas. Exclusion criteria
included the inability to complete the study procedures,
inability/unwillingness to provide voluntary written in-
formed consent, and gambling frequency of less than ﬁve
times in the past year. No medications were administered as
a part of this study. Subjects taking medications were
allowed to take part in the research.
Measurements
Demographics. Age, gender, marital status, educational
status, professional status, ethnicity, and sexual orientation
were recorded.
Severity of anxiety symptoms. The Hamilton Anxiety
Scale (HAM-A) is a valid and reliable instrument that
assesses cross-sectional severity of anxiety symptoms
(Hamilton, 1969; Maier, Buller, Philipp, & Heuser, 1988;
Snaith, Baugh, Clayden, Husain, & Sipple, 1982). The
HAM-A consists of 14 items (score range 0–56) that
evaluate a variety of anxiety symptoms (Beck & Steer,
1991). HAM-A total score presents an intra-class coefﬁcient
of 0.74 and a concurrent validity between 0.63 and
0.75 (Maier et al., 1988). The HAM-A has shown good
internal consistency (Cronbach’s alpha= .893) (Kummer,
Cardoso, & Teixeira, 2010). It is probably the most used and
accepted scale to evaluate anxiety symptoms.
Clinical variables.
1. Gambling behavior: we evaluated the age at the start
of regular gambling, the amount of money lost with
gambling in the last year, and the average gambling
frequency (times per week).
2. Overall severity of GD: we assessed the total num-
ber of DSM-5 GD criteria using the Structured
Clinical Interview for Gambling Disorder (SCI-PG)
(Grant, Steinberg, Kim, Rounsaville, & Potenza,
2004). SCI-PG was ﬁrst validated using the criteria
of the Fourth Edition of the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM-4). Test–
retest reliability on the number of GD criteria
endorsed showed r= .97 (p= .006) (Grant et al.,
2004). We retrospectively processed the electronic
saved DSM-4 criteria for a proper adaptation to
DSM-5. This procedure was performed deleting the
criterion “committed illegal acts such as forgery,
fraud, theft, or embezzlement to ﬁnance gambling
regarding illegal acts,” which was present in the
previous manual, DSM-4. Moreover, we lowered the
diagnostic threshold from ﬁve to four, consistent
with DSM-5. Remaining criteria were unchanged.
Severity was divided in three categories: recreational
gambling (meets 0 DSM-5 criteria), subsyndromal
GD (meets 1–3 DSM-5 criteria) and GD (meets 4 or
more DSM-5 criteria).
In addition, we investigated the overall gambling
severity with the Pathological Gambling Yale-Brown
Obsessive-Compulsive Scale (PG-YBOCS). It is a
10-item scale that showed high validity (r= .895) and
reliability (Cronbach’s α= .970) (Pallanti, DeCaria,
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Grant, Urpe, & Hollander, 2005). This scale provides
a total score (overall severity) as well as scores in
two subscales (urges and behavior subscales).
3. Impulsiveness: evaluated by the Barratt Impulsive-
ness Scale, version 11 (BIS-11) (Patton & Stanford,
1995), a scale that has been largely used to investigate
impulsiveness (Steinberg, Sharp, Stanford, & Tharp,
2013). This scale has shown good internal consistency
(Cronbach’s α between .79 and .83) (Patton &
Stanford, 1995). BIS-11 provides scores in three
different dimensions, based on previous factor analy-
ses: attentional impulsiveness, motor impulsiveness,
and non-planning impulsiveness (Patton & Stanford,
1995).
4. Prevalence of illegal acts: the commitment of illegal
acts to ﬁnance gambling activity has been associated
with higher severity of GD (Granero et al., 2015;
Strong & Kahler, 2007; Toce-Gerstein et al., 2003). It
was evaluated using an open question using previous
DSM-4 criteria: “Have you committed illegal acts
such as forgery, fraud, theft, or embezzlement to
ﬁnance gambling?”
5. Suicidality and psychiatric comorbidity: evaluated by
the Mini-International Neuropsychiatric Interview
(MINI) (Sheehan et al., 1998).
6. Quality of life (quality of life inventory): a 17-item
scale that evaluates the subject’s overall quality of life
(Frisch, 1994). Alpha coefﬁcients and test–retest cor-
relations for this questionnaire have ranged, respec-
tively, from 0.77 to 0.89 and from 0.80 to 0.91
(Mendlowicz & Stein, 2014).
7. Use of nicotine: assessed by a 20-cigarette pack per
day equivalent.
Neurocognitive testing. Individuals with GD tend to
present with several neurocognitive deﬁcits such as poorer
response inhibition, low cognitive ﬂexibility, worse decision
making, and problems with sustained attention and execu-
tive functioning (Clark, 2010; Van Holst, van den Brink,
Veltman, & Goudriaan, 2010). This study evaluated
whether anxiety symptoms affected any of these neuropsy-
chological variables. In this context, participants undertook
selected tests from the computerized Cambridge Neuropsy-
chological Test Automated Battery (CANTABeclipse,
version 3, Cambridge Cognition Ltd., Cambridge, UK)
(Cambridge Cognition, 2015). Task order was ﬁxed and
the total duration of cognitive testing was approximately
50 min.
1. Response inhibition: assessed by the stop-signal task,
which assesses the subject’s ability to inhibit/suppress
motor responses. Individuals react to an arrow stimu-
lus, by touching either a left or right key depending on
the direction in which the arrow points. When an
audio tone occurs, the participant attempts to suppress
their motor response for the particular trial (Morein-
Zamir & Sahakian, 2010). The outcome measure of
interest is the stop-signal reaction time, an index of the
time taken for the person’s brain to stop a response
that would normally be made.
2. Cognitive ﬂexibility: investigated with the intra-
dimensional/extra-dimensional set shifting test, which
evaluates rule learning, reversal, and shifting of
attentional focus across stimulus dimensions. The test
uses visual stimuli (colorful shapes and white lines)
and gives feedback to the individual so that they are
able to learn an underlying “rule” about which stimu-
lus is correct, based on trial and error. The underlining
rule that determines what is “correct” and “incorrect”
changes several times and assesses the individual’s
ability to respond with ﬂexibility (Cambrigde Cogni-
tion, 2015). The adjusted total number of errors is an
overall score of performance.
3. Decision making: assessed using the Cambridge
Gamble Task, a test that assesses decision making
and risk taking (Cambridge Cognition, 2015; Dea-
kin, Aitken, Robbins, & Sahakian, 2004; Lawr-
ence, Luty, Bogdan, Sahakian, & Clark, 2009). The
task simulates gambling activity but uses points for
bets, rather than “real” rewards. The main outcome
measures in this test are: quality of decision
making, proportion of points gambled, and risk
adjustment.
4. Sustained attention: evaluated by the Rapid Visual
Information Processing paradigm. This task investi-
gates the ability to detect unpredictable target
sequences over prolonged period of time (Sarter,
Givens, & Bruno, 2001). The task consists of a
white box in the center of the computer screen,
inside which numbers, from 2 to 9, show up in a
pseudo-random manner, at the frequency of
100 digits/min. A′ was used as a measure of
sustained attention.
5. Executive functioning: assessed using the One
touch stockings of Cambridge task. This test, a
variant of a variation of the Tower of London (Owen
et al., 1995), investigates goal-directed planning
(Cambridge Cognition, 2015). The task presents
visual problems to the subject and evaluates the
individual’s ability to plan a solution and answer
these problems.
Statistical analysis
We analyzed the association between the severity of anxiety
symptoms and demographic, clinical, and neurocognitive
variables of the participants using Spearman’s coefﬁcients
for continuous elements and Mann–Whitney tests for cate-
gorical variables.
To control for multiple comparisons, we divided the
usual level of signiﬁcance (p= .05) by the number of
variables evaluated in each group of assessments
(i.e., clinical variables and neurocognitive testing). Conse-
quently, signiﬁcance was deﬁned as p≤ .004 (.05/13= .004)
for clinical variables and p≤ .007 (.05/7= .007) for neuro-
cognitive variables.
To reduce the likelihood of confounding variables
contributing to the above analyses, we controlled for current
major-depressive disorder, alcohol-use disorder, substance-
use disorder, and nicotine use. These controls were includ-
ed, as all four variables have demonstrated signiﬁcant
overlap with anxiety symptoms and several clinical/neuro-
cognitive variables investigated in this study, in prior work
(Clark, 2010; Maier et al., 1988).
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Ethics
This research was approved by the Institutional Review
Boards of the University of Chicago and the University of
Minnesota. The study procedures were explained to the
participants prior to providing consent, and all participants
were given time to ask questions. All participants provided
written informed consent.
RESULTS
Table 1 describes the demographics and main clinical
variables of our sample.
There was a signiﬁcant positive correlation between the
severity of anxiety symptoms and the number of current
DSM-5 GD criteria. In addition, the quality of life was
negatively correlated with the severity of anxiety symptoms.
The presence of suicidality in gamblers was also associated
with signiﬁcantly higher scores on HAM-A, even after
controlling for major depression, alcohol-use disorders,
substance-use disorder, and use of nicotine (see also the
ﬁndings using ANOVA, Figure 1). The analysis also
showed a direct correlation between anxiety symptoms in
gamblers and higher scores on the attentional impulsivity
dimension of BIS (i.e., higher attentional impulsiveness)
(see Table 2).
We did not ﬁnd signiﬁcant correlations between neuro-
cognitive variables and anxiety symptoms (see Table 3).
DISCUSSION AND CONCLUSIONS
This study analyzed the association of anxiety symptoms,
gambling clinical variables, and neurocognitive variables in
non-treatment-seeking gamblers. We evaluated subjects
with a wide range of gambling severity (individuals who
meet 0–9 DSM-5 GD criteria) and with different levels of
anxiety (HAM-A scores from 0 to 28). The use of a non-
treatment-seeking sample was important to achieve this
spread of disease severities, to maximize the ability to detect
the relationships between variables. Treatment-seeking
gamblers tend to be more severe than gamblers in the
general population (Petry et al., 2005) and therefore, the
range of different levels of gambling activity is narrower in
treatment-seeking samples. In addition, treatment-seeking
gamblers may present a signiﬁcant selection bias. Therefore,
the use of a non-treatment-seeking sample enabled us to
assess the association between anxiety, gambling, and
neurocognition throughout a broad spectrum of gambling
and anxiety levels.
This study found that the severity of anxiety symptoms
was associated with several important clinical variables,
even when controlling for major depression, alcohol-use
disorder, substance-use disorder, and use of nicotine. There
was a positive correlation between anxiety and gambling
severities measured by the number of DSM-5 GD criteria
met. There was also a positive correlation between anxiety
severity and attentional impulsiveness. Participants with
suicidality presented with higher levels of anxiety. Finally,
the severity of anxiety symptoms was negatively correlated
with the quality of life.
The number of DSM-5 criteria endorsed showed a posi-
tive correlation with anxiety levels. There was no signiﬁcant
correlation, however, between gambling severity, as mea-
sured by PG-YBOCS, and anxiety. The DSM-5 criteria
assess the symptoms over the past year, whereas the PG-
YBOCS was designed to evaluate severity during the past 7
days. Given that the anxiety is often a chronic condition; the
DSM-5 criteria may more accurately capture the impact of
these symptoms on gambling behavior.
A large epidemiological study suggested that anxiety
disorders usually precede GD and appear to trigger gam-
bling problems (Kessler et al., 2008). The longitudinal
relationship between anxiety symptoms and gambling ac-
tivity, after gambling has started, remains unclear. In this
context, important questions remain: do gamblers have a
more harmful gambling activity due to higher anxiety
levels? Or, does having severe gambling problems and,
therefore more negative consequences, make gamblers feel
more anxious? Future longitudinal studies should address
this point.
The ﬁnding that anxiety levels were positively correlated
with gambling severity is clinically important, and proper
Table 1. Description of demographics and main clinical variables
of non-treatment-seeking gamblers (n= 143)
Demographics % (n) or mean (SD)
Age 24.8 (±2.9)
Gender
Male 52.4 (75)
Female 47.6 (68)
Marital status
With partner 79.7 (114)
Without partner 20.3 (29)
Educational status
Less than college 53.8 (77)
College or more 46.2 (66)
Occupational status
Studying or working 81.8 (117)
Unemployed 18.2 (26)
Ethnicity
Caucasian 43.3 (61)
Non-Caucasian 56.7 (80)
Sexual orientation
Heterosexual 83.9 (120)
Other 16.1 (23)
Clinical variables
Anxiety symptoms severity
(Hamilton Anxiety Scale)
6.1 (±6.3)
Age at the start of regular gambling 18.9 (±3.0)
Money lost with gambling (last year) 2,221 (±4,325)
Average gambling frequency
(times per week)
2.9 (±2.9)
Number of DSM-5 gambling
disorder criteria
2.0 (±2.6)
PG-YBOCS total score 7.9 (±8.1)
Note. SD, standard deviation; DSM-5, Diagnostic and Statistical
Manual of Mental Disorders – Fifth Edition; PG-YBOCS, gam-
bling adaptation of the Yale-Brown Obsessive-Compulsive Scale.
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management of anxiety may improve treatment outcomes in
gambling problems. Psychological therapies should address
anxiety while identifying the reasons for gambling or for
worsening of bets. Relaxation techniques and alternative
ways to deal with anxiety (other than gambling) might be
useful. Pharmacological approaches, such as the use of
selective serotonin re-uptake inhibitors, may also enhance
the control of anxiety. Grant and Potenza (2006) found that
the use of escitalopram in a sample of disordered gamblers
with co-occurring anxiety signiﬁcantly improved gambling
and anxiety symptoms. Future clinical trials looking specif-
ically at anxious gamblers are needed.
Figure 1. Association between the severity of anxiety symptoms and the level of suicidality in non-treatment-seeking gamblers (n= 138).
ap value controlled for major depressive disorder, alcohol-use disorder, substance-use disorder, and smoking. bThe level of suicidality was
deﬁned by the MINI-score that accesses the risk of suicide in the past month. Suicidality is considered low (scores between 1 and 8 points),
moderate (scores between 9 and 16 points), and high (scores≥ 17)
Table 2. Association between clinical variables and anxiety levels in non-treatment-seeking gamblers (n= 143)
Clinical variables
Spearman’s correlation coefﬁcient
or mean HAM-A (SD) p valuea
Adjusted correlation coefﬁcientb
or effect size
Adjusted p
valueb
Age started gambling regularly −.170 .043 −.135 .146
Money lost with gambling
(last year)
.222 .008 .122 .186
Average gambling frequency
(times per week)
.110 .192 .048 .604
Number of DSM-5 gambling
disorder criteria
.374 <.001 .363 <.001
PG-YBOCS total score .345 <.001 .213 .019
PG-YBOCS urges subscale .341 <.001 .183 .046
PG-YBOCS gambling
behavior subscale
.307 <.001 .229 .012
Barratt Impulsiveness Scale
Attentional .328 <.001 .290 .001
Motor .250 .003 .198 .032
Lack of planning .236 .005 .088 .344
Legal problems due to gambling
(yes/no)
2.5 (±2.1)/6.2 (±6.4) .437 −.036 .439
Suicidality in the past month
(yes/no)
10.1 (±7.2)/4.5 (±5.2) <.001 .040 <.001
Quality of life (quality of life
inventory)
−.343 <.001 −.292 .001
Note. HAM-A, Hamilton Anxiety Scale; SD, standard deviation; DSM-5, Diagnostic and Statistical Manual of Mental Disorders –
Fifth Edition; PG-YBOCS, gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale.
aSigniﬁcance was deﬁned as p≤ .004 (.05/13= .004) for clinical variables. bAdjusted for current major-depressive, alcohol-use disorder,
substance-use disorder, and nicotine use.
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This study observed a positive correlation between at-
tentional impulsiveness as indexed by the Barratt question-
naire, and severity of anxiety symptoms; and between worse
sustained attention on a computerized task, and severity of
anxiety symptoms. Attentional impulsiveness has been
described as an inability to keep attention/concentration
(Stanford et al., 2009). When the BIS was ﬁrst developed,
attentional impulsiveness was believed to be an isolated
dimension together with motor impulsiveness and lack of
planning (Barratt, 1959). Later research suggested that it is
an underlying construct that interacts with motor impulsive-
ness and lack of planning (Patton & Stanford, 1995).
Therefore, attentional impulsiveness may be considered as
a dimension that is correlated with impulsiveness in several
levels (Patton & Stanford, 1995).
Attentional bias is a well-characterized phenomenon in
anxious individuals, who preferably allocate attention/focus
on threatening stimuli rather than on neutral stimuli
(Bar-Haim et al., 2007; MacLeod et al., 1986; Mogg &
Bradley, 1998). This attentional bias to threat also leads to
slower disengagement from threatening elements and, as a
result of this, other non-threatening elements tend to be less
perceived (Bishop et al., 2004; Koster et al., 2004, 2006;
Schoﬁeld et al., 2012). Therefore, an anxious individual
who gambles may have a reduced focus on the gambling
behavior (i.e., how to bet and how much to bet). Future
studies might further investigate how the attentional bias
interferes in gambling activity and could, particularly, look
at possible threatening stimuli that are over-perceived dur-
ing gambling behavior.
This study also observed that the severity of anxiety
symptoms was positively associated with the presence of
suicidality (Figure 1).
This is an important ﬁnding for several reasons. First,
suicide has a huge economic impact in the United States.
For example, in 2010, the ﬁnancial losses associated
with suicide were estimated at 44 billion US dollars/year
(American Foundation for Suicide Prevention, 2010).
Second, suicide is a top 2 leading cause of death in
the United States for subjects aged 15–34 years (Centers
for Disease Control and Prevention, 2011), the popula-
tion evaluated by this study. Third, GD and subsyndro-
mal GD have been associated with higher rates of
suicide ideation/attempts (Bland et al., 1993; Hodgins,
Mansley, & Thygesen, 2006; Newman & Thompson,
2007). Therefore, young gamblers appear to have a
substantially elevated risk for suicide (age + gambling
activity).
Unlike this research, the majority of previous studies that
assessed suicide/risk of suicide in gamblers did not report a
signiﬁcant correlation between anxiety and suicidality. Two
facts may explain this as follows: (a) some studies failed to
assess the relationship between anxiety symptoms/anxiety
disorders and suicide (see Hodgins et al., 2006) and (b) this
study evaluated only young adults (aged 18–29 years), a
group with higher anxiety symptoms, and higher suicidality
(Centers for Disease Control and Prevention, 2011; Martin,
2003). Therefore, anxiety symptoms may present a higher
impact on suicidality in young gamblers and we evaluated a
broad spectrum of gambling activity.
In fact, Grant et al. (2014) used a subsyndromal GD
sample and found an association between suicidality and
anxiety disorders. However, the assessment of suicidality
did not control for other mental disorders as this study did.
As the correlation between GD and suicide ideation/
attempts has been strongly attributed to co-occurring major
depressive disorder and alcohol-/substance-use disorders
(Crockford & el-Guebaly, 1998; Hodgins et al., 2006), our
study strengthens the possible separate association of anxi-
ety symptoms and suicidality in gamblers.
A meta-analysis of 42 studies conducted by Kanwar et al.
(2013) suggested that anxiety disorders are associated with
higher suicidality (Kanwar et al., 2013). Better assessment
of anxiety symptoms, particularly in gamblers with suicid-
ality seems to be important in clinical practice. As anxiety
symptoms/disorders are considered relatively treatable
(Hofmann & Smits, 2008), a more focused management
in anxious gamblers may possibly reduce suicide risk.
Table 3. Association between neurocognitive variables and anxiety level in non-treatment-seeking gamblers (n= 143)
Neurocognitive variables
Spearman’s correlation
coefﬁcient p valuea
Adjusted correlation
coefﬁcientb
Adjusted p
valueb
Response inhibition (delay at the stop-signal test)c .051 .546 .047 .617
Decision making (Cambridge gamble task)
Quality of decision making −.093 .273 −.109 .243
Overall proportion bet .124 .141 .128 .172
Risk adjustment −.131 .120 −.169 .070
Cognitive ﬂexibility (intra–extra-dimensional
set shifting test)
.170 .044 .158 .091
Sustained attention (rapid visual information
processing)
−.235 .005 −.153 .101
Executive functioning (one touch stockings
of Cambridge)
−.209 .014 −.102 .274
aSigniﬁcance was deﬁned as p≤ .007 (.05/7= .007) for neurocognitive variables. bAdjusted for current major-depressive, alcohol-use
disorder, substance-use disorder, and nicotine use. cThe following measures were used: [delay at stop-signal test]= stop-signal reaction time
(ms); [intra–extra dimensional set shifting test]= total errors (adjusted); [rapid visual information processing]= proportion of targets
detected; [one touch stockings of Cambridge]= problems solved in minimum possible number of moves.
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Our study found that severity of anxiety was negatively
correlated with the quality of life. This ﬁnding is consistent
with previous epidemiological and clinical studies that have
shown that anxiety disorders and subthreshold forms of
anxiety disorders are associated with signiﬁcantly reduced
quality of life (Kessler et al., 1994; Markowitz, Weissman,
Ouellette, Lish, & Klerman, 1989; Mendlowicz & Stein,
2014; Spitzer et al., 1995; Weissman, 1991; Wittchen, 2002;
Wittchen, Carter, Pﬁster, Montgomery, & Kessler, 2000;
Zatzick et al., 2014). On the other hand, subsyndromal GD
and GD have also been associated with poorer life satisfac-
tion when compared with the general population (Black,
Moyer, & Schlosser, 2003; Grant & Kim, 2005). Therefore,
this study reinforces the negative correlation between anxi-
ety and decreased quality of life in a non-treatment-seeking
sample of impulsive patients.
Quality of life is a core dimension in psychiatry treat-
ments and, as a result of this, this variable has been
increasingly recognized as a main outcome measure in
clinical trials (Group for the Advancement of Psychiatry
Committee on Psychopathology, 1994; Johnson & Temple,
1985; Pietersma, de Vries, & van den Akker-van, 2014;
Spitzer et al., 1995; Wilson & Cleary, 1995). Anxiety may
selectively affect some areas of quality of life. Spitzer et al.
suggested that patients with anxiety disorders presented
decreased scores particularly in role functioning. Further
research should look at the effects of anxiety in speciﬁc
dimensions. Cognitive-behavioral therapy focusing on
training of social skills may beneﬁt anxious gambling
individuals.
This study should be interpreted in light of its limitations.
First, this research used a cross-sectional analysis and,
therefore, causal relationships cannot be conﬁrmed. How-
ever, the analysis provides reliable measures of association.
Second, some of the data collected (age at the start of
recreational gambling and money lost with gambling in the
last year) may be subject to potential recall bias, as it was
collected in hindsight. Third, our sample consisted of a
convenience sample of young adults (individuals aged
18–29 years). Therefore, caution is needed when generaliz-
ing our ﬁndings to broader segments of the population.
Finally, our study used a low signiﬁcance level [i.e., .004 for
(clinical variables) and .007 for (neurocognitive variables)].
Therefore, we increased the likelihood of committing Type
II error. On the other hand, we reduced the risk of ﬁnding
false-positive results.
This study suggests that anxiety may be associated with
relevant clinical variables in the broad spectrum of gam-
bling activity. Therefore, proper management of anxiety
symptoms might improve the clinical presentation of gam-
blers in different areas: (a) reducing the overall gambling
severity; (b) improving the attentional deﬁcits and attempt-
ing to reduce attentional impulsiveness; (c) reducing the
risk/severity of suicidality; and (d) improving the quality of
life.
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